betaine glucuronate

Betaine glucuronate is a compound formed by the esterification of betaine and glucuronic acid. It has been investigated for its potential therapeutic applications, particularly in liver health, such as in the management of non-alcoholic steatohepatitis (NASH). It acts primarily through its osmoprotective properties, helping to maintain cellular osmotic balance and stabilizing protein structures and functions under stress conditions. In hepatocytes, it modulates immune responses by preventing hyperosmolarity-induced suppression of tumor necrosis factor-alpha release and influencing prostaglandin formation. Its mechanism is also understood by examining the distinct roles of its two constituent moieties: betaine, which acts as a methyl donor in the methionine-homocysteine cycle and an organic osmolyte, and glucuronic acid, which is involved in detoxification processes. Clinical evidence primarily comes from studies where it is part of a combination therapy, such as "Ietepar", which showed effectiveness in reducing hepatic steatosis, hepatomegaly, and liver transaminases in NASH.

Other names

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-(trimethylammonio)acetoxy)tetrahydro-2H-pyran-2-carboxylateEthanaminium, 2-(β-D-glucopyranuronosyloxy)-N,N,N-trimethyl-2-oxo-, inner saltAmmonium, (carboxymethyl)trimethyl-, hydroxide, β-D-glucopyranuronosyl ester, inner salt